These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 29396392)
1. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma. Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392 [TBL] [Abstract][Full Text] [Related]
2. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types. Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197 [TBL] [Abstract][Full Text] [Related]
3. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus upregulates the expression of kinesin family member 4A. Zhu CL; Cheng DZ; Liu F; Yan XH; Wu KL; Wang FB; Liu XH Mol Med Rep; 2015 Sep; 12(3):3503-3507. PubMed ID: 25998931 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Bai L; Ren Y; Cui T J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490 [TBL] [Abstract][Full Text] [Related]
6. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Sui Y; Zheng X; Zhao D Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564 [TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway. Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712 [TBL] [Abstract][Full Text] [Related]
9. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway. Wu L; Zheng J; Chen P; Liu Q; Yuan Y Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966 [TBL] [Abstract][Full Text] [Related]
10. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma. Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309 [TBL] [Abstract][Full Text] [Related]
11. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
12. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma. Lin MF; Yang YF; Peng ZP; Zhang MF; Liang JY; Chen W; Liu XH; Zheng YL Int J Biochem Cell Biol; 2017 Jul; 88():155-161. PubMed ID: 28506857 [TBL] [Abstract][Full Text] [Related]
13. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. Wang J; Luo Z; Yao T; Li W; Pu J J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590 [TBL] [Abstract][Full Text] [Related]
14. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway. Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells. Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264 [TBL] [Abstract][Full Text] [Related]
17. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155 [TBL] [Abstract][Full Text] [Related]
19. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]